相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Glycemic Variability Is a Powerful Independent Predictive Factor of Midterm Major Adverse Cardiac Events in Patients With Diabetes With Acute Coronary Syndrome
Edouard Gerbaud et al.
DIABETES CARE (2019)
Glycaemic variability in diabetes: clinical and therapeutic implications
Antonio Ceriello et al.
LANCET DIABETES & ENDOCRINOLOGY (2019)
Glycemic variability in continuous glucose monitoring is inversely associated with baroreflex sensitivity in type 2 diabetes: a preliminary report
Daisuke Matsutani et al.
CARDIOVASCULAR DIABETOLOGY (2018)
Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study
C. R. L. Cardoso et al.
CARDIOVASCULAR DIABETOLOGY (2018)
Platelet function following induced hypoglycaemia in type 2 diabetes
H. Kahal et al.
DIABETES & METABOLISM (2018)
Accuracy of flash glucose monitoring and continuous glucose monitoring technologies: Implications for clinical practice
Ramzi A. Ajjan et al.
DIABETES & VASCULAR DISEASE RESEARCH (2018)
Improvements of ambient hyperglycemia and glycemic variability are associated with reduction in oxidative stress for patients with type 2 diabetes
Makoto Ohara et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2018)
Glycemic variability in the development of cardiovascular complications in diabetes
Annunziata Nusca et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2018)
Association Between Use of Sodium-Glucose Cotransporter 2 Inhibitors, Glucagon-like Peptide 1 Agonists, and Dipeptidyl Peptidase 4 Inhibitors With All-Cause Mortality in Patients With Type 2 Diabetes A Systematic Review and Meta-analysis
Sean L. Zheng et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Glycemic variability determined with a continuous glucose monitoring system can predict prognosis after acute coronary syndrome
Hironori Takahashi et al.
CARDIOVASCULAR DIABETOLOGY (2018)
Glycemic variability is associated with myocardial damage in nondiabetic patients with ST-elevation myocardial infarction
Satoshi Oka et al.
CARDIOVASCULAR ENDOCRINOLOGY & METABOLISM (2018)
Glycemic Targets: Standards of Medical Care in Diabetes-2018
DIABETES CARE (2018)
Exenatide once weekly improved 24-hour glucose control and reduced glycaemic variability in metformin-treated participants with type 2 diabetes: a randomized, placebo-controlled trial
Juan P. Frias et al.
DIABETES OBESITY & METABOLISM (2017)
Antithrombotic potency of ticagrelor versus clopidogrel in type-2 diabetic patients with cardiovascular disease
M. Urooj Zafar et al.
THROMBOSIS AND HAEMOSTASIS (2017)
Glucagon-like peptide 1-related peptides increase nitric oxide effects to reduce platelet activation
Cristina Barale et al.
THROMBOSIS AND HAEMOSTASIS (2017)
Impact of Hemoglobin A1c Levels on Residual Platelet Reactivity and Outcomes After Insertion of Coronary Drug-Eluting Stents (from the ADAPT-DES Study)
Mikkel M. Schoos et al.
AMERICAN JOURNAL OF CARDIOLOGY (2016)
Pharmacodynamic Comparison of Prasugrel Versus Ticagrelor in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease The OPTIMUS (Optimizing Antiplatelet Therapy in Diabetes Mellitus)-4 Study
Francesco Franchi et al.
CIRCULATION (2016)
Glucagon-Like Peptide 1 Receptor Activation Attenuates Platelet Aggregation and Thrombosis
Alison Cameron-Vendrig et al.
DIABETES (2016)
Association between blood glucose variability and coronary plaque instability in patients with acute coronary syndromes
Kozo Okada et al.
CARDIOVASCULAR DIABETOLOGY (2015)
Excess Mortality among Persons with Type 2 Diabetes
Mauro Tancredi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Glycemic Variability Assessed by Continuous Glucose Monitoring and Short-Term Outcome in Diabetic Patients Undergoing Percutaneous Coronary Intervention: An Observational Pilot Study
Annunziata Nusca et al.
JOURNAL OF DIABETES RESEARCH (2015)
Effect of intensive glycemic control on platelet reactivity in patients with long-standing uncontrolled diabetes
Joelle Singer et al.
THROMBOSIS RESEARCH (2014)
Impaired inhibition of P2Y12 by clopidogrel is a major determinant of cardiac death in diabetes mellitus patients treated by percutaneous coronary intervention
S. El Ghannudi et al.
ATHEROSCLEROSIS (2011)
Impact of Platelet Reactivity on Clinical Outcomes After Percutaneous Coronary Intervention A Collaborative Meta-Analysis of Individual Participant Data
Somjot S. Brar et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Lack of correlation between platelet reactivity and glycaemic control in type 2 diabetes mellitus patients treated with aspirin and clopidogrel
Fabio Mangiacapra et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2011)
Comparison of Platelet Reactivity and Periprocedural Outcomes in Patients With Versus Without Diabetes Mellitus and Treated With Clopidogrel and Percutaneous Coronary Intervention
Fabio Mangiacapra et al.
AMERICAN JOURNAL OF CARDIOLOGY (2010)
Periprocedural Myocardial Infarction Prevalence, Prognosis, and Prevention
Alexandra J. Lansky et al.
CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2010)
Comparative Determinants of 4-Year Cardiovascular Event Rates in Stable Outpatients at Risk of or With Atherothrombosis
Deepak L. Bhatt et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Beyond Hemoglobin A1c-Need for Additional Markers of Risk for Diabetic Microvascular Complications
Irl B. Hirsch et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Effects of vildagliptin twice daily vs. sitagliptin once daily on 24-hour acute glucose fluctuations
Raffaele Marfella et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2010)
Consensus and Future Directions on the Definition of High On-Treatment Platelet Reactivity to Adenosine Diphosphate
Laurent Bonello et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Postprandial hyperglycemia is a determinant of platelet activation in early type 2 diabetes mellitus
F. Santilli et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
The relation between platelet reactivity and glycemic control in diabetic patients with cardiovascular disease on maintenance aspirin and clopidogrel therapy
Anand Singla et al.
AMERICAN HEART JOURNAL (2009)
Enhanced post-clopidogrel platelet reactivity in diabetic patients is independently related to plasma fibrinogen level but not to glycemic control
B. Gaborit et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Point-of-care measurement of clopidogrel responsiveness predicts clinical outcome in patients undergoing percutaneous coronary intervention - Results of the ARMYDA-PRO (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platelet Reactivity Predicts Outcome) Study
Giuseppe Patti et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Impact of platelet reactivity on cardiovascular outcomes in patients with type 2 diabetes mellitus and coronary artery disease
Dominick J. Angiolillo et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Chronic hyperglycemia but not glucose variability determines HbA1c levels in well-controlled patients with type 2 diabetes
Klaus-Dieter Kohnert et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2007)
Randomized comparison of a high clopidogrel maintenance dose in patients with diabetes mellitus and coronary artery disease - Results of the Optimizing antiPlatelet Therapy In diabetes MellitUS (OPTIMUS) study
Dominick J. Angiolillo et al.
CIRCULATION (2007)
Isolated elevation in troponin T after percutaneous coronary intervention is associated with higher long-term mortality
Abhiram Prasad et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Insulin therapy is associated with platelet dysfunction in patients with type 2 diabetes mellitus on dual oral antiplatelet treatment
Dominick J. Angiolillo et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Acute, short-term hyperglycemia enhances shear stress-induced platelet activation in patients with Type II diabetes mellitus
P Gresele et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
分享论文
